Adherence to treatment in type 2 diabetes mellitus patients receiving multiple drug therapy
Keywords:Adherence, Morisky questionnaire, Polypharmacy, Type 2 diabetes
Background: objective of the study was to evaluate adherence to therapy and factors associated with non-adherence in type 2 diabetes mellitus patients on multiple drug therapy.
Methods: A prospective, cross-sectional, questionnaire based study conducted on 100 type 2 DM patients in a tertiary teaching hospital. They were interviewed using self-designed, semi-structured questionnaire to assess adherence to medication and diet/exercise schedule. Morisky medication adherence questionnaire was used to calculate overall adherence.
Results: 71%patients had some co-morbidity and were on multiple medications. Average daily modifications taken by patients was 4.1±2.23 (mean+SD). Only 47% patients were found adherent. Illiteracy (11%), Language (10%), complicated dosages (8%), adverse drug events (6%), heavy outpatient load (6%), psychological illness (6%), and financial (4%) were common reasons for non-adherence. Surprisingly, total number of medicines prescribed did not interfere with adherence.58% patients were aware of the importance of medication, diet and exercise but 42% patients were not aware of the consequences of non-adherence. 65% patients adhered to diet control and 43% patients followed exercise schedule.
Conclusions: 53% of type 2 DM patients on multi-drug therapy were not adhering to prescribed medication making it a major hurdle to its management. The most important cause of non adherence were not comprehending instructions due to various reasons like illiteracy, language issues, complicated schedules and less doctor-patient interaction due to heavy OPDs. Also 42% of the patients were not aware of the consequences of non adherence to therapy, diet and exercise. Hence, a multidimensional approach with adequate medication and emphasis on adherence to prescribed medication, diet and exercise schedule requires implemented. Health professionals can play a major role in improving adherence by increasing interaction with patients.
Sharma T, Kalra J, Dhasama DC, Basera H. Poor adherence to therapy: A major challenge in diabetes. JIACM. 2014;15(1):26-9.
World Health Organization: Adherence to long-term therapies: Evidence for action. Available at: http://www.who.int/chp/knowledge/publications/adherence_report/en/. (Last accessed on 27/04/2019).
García-Pérez LE, Álvarez M, Dilla T, Gil-Guillén V, Orozco-Beltrán D. Adherence to therapies in patients with type 2 diabetes. Diabetes Therapy. 2013 Dec 1;4(2):175-94.
Sontakke S, Jadhav M, Pimpalkhute S, Jaiswal K, Bajait C. Evaluation of adherence to therapy in patients of type 2 diabetes mellitus. J Young Pharma. 2015 Oct 1;7(4):462-9.
Gomes MD. Impact of diabetes on cardiovascular disease: an update. Int J Hypert. 2013 Mar 4;2013.
American Diabetes association. Standards of medical care in diabetes - 2015 abridged for primary care providers. Clin Diabetes. 2015;33(2):97-111.
Wincour PH. Effective diabetes care: a need for realistic targets. BMJ. 2002;324:1557-80.
David B Hogan and Marylin Kwan. Patient sheet: Tips for avoiding problems with polypharmacy. CMAJ. 2006 Oct 10;175(8):876.
Austin RP. Polypharmacy as a risk factor in the treatment of type 2 diabetes. Diabetes Spectrum. 2006 Jan 1;19(1):13-6.
Katzung BG. Development & Regulation of Drugs. Basic and Clinical Pharmacology. 12th ed. New Delhi: Tata McGraw-Hill; 2012 Jan 3:69-77.
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-97.
Ahmad NS, Ramli A, Islahudin F, Paraidathathu T. Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia. Patient Prefer Adherence. 2013;17(7):525-30.
Morisky DE, Green LW, Levune DM. Concurrent & predictive validity of a self reported measure of medication adherence. Med Care. 1986;24:67-74.
Waleed Sweileh, Ola Aker and Saeed Hamooz. Effect of Polypharmacy and Frequency of Drug Dosing on Rate of Compliance among Diabetic and Hypertensive Patients: A Survey Study in Palestine. An-Najah Univ J Res N Sc. 2003;7(2):155-63.
Kirkman MS, Rowan-Martin MT, Levin R, Fonseca VA, Schmittdiel JA, Herman WH, et al. Determinants of adherence to diabetes medications: findings from a large pharmacy claims database. Diabetes care. 2015 Apr 1;38(4):604-9.
Goldberg RM, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Amer J Emerg Med. 1996 Sep 1;14(5):447-50.